Madison Muller

Alan Hibbard, Precious Metals and Alternative Money Specialist at GoldSilver.com, discusses the rising significance of gold as a safe haven, projecting prices may soar beyond $3,000 per ounce by 2025, while contrasting it with Bitcoin's challenges as a transactional currency. Madison Muller, Bloomberg News Health Reporter, dives into the healthcare sector's future, highlighting the impact of emerging weight loss drugs and potential market challenges, including accessibility and competition driven by telehealth innovations.

Madison Muller, a healthcare reporter for Bloomberg News, dives deep into the rise of Hims, a company that pivoted from niche health services to capitalize on the weight-loss drug craze. She reveals how Hims seized market share with its copycat versions of medications like Ozempic as customers flocked during drug shortages. However, as the FDA declares the shortage over, Muller discusses the challenges Hims faces with dwindling demand and evolving consumer perceptions—leading to a gripping narrative of innovation amidst regulatory hurdles.

Kathryn Judge, a constitutional law professor, explains the Supreme Court ruling curbing presidential tariff power. Ryan Vlastelica, an equities reporter, breaks down market reactions and AI-driven sector moves. Madison Muller, a health reporter, covers GLP-1 drug competition and pharma trial shakeups. They discuss legal limits, market volatility, and shifts in the obesity-treatment landscape in short, sharp segments.

Denise Paulonis, CEO of Sally Beauty, on retail trends and DIY vs pro markets. Joyce Huang, fixed-income portfolio manager, on yields, credit spreads and macro drivers. Madison Muller, Bloomberg health reporter, on GLP-1 litigation and pharma competition. Stuart Kaiser, Citi trading strategist, on tech momentum, AI capex winners and seasonal market dynamics.

In this discussion, Madison Muller, a Bloomberg reporter specializing in pharmaceuticals, explores the explosive growth of weight-loss drugs like Ozempic and Wegovy through telehealth. She highlights the dangers of easy access to these medications, particularly for those recovering from eating disorders. Personal accounts reveal the allure and risks of appetite suppressants, stressing the need for responsible prescribing practices. Muller's insights shine a light on the critical balance between accessibility and patient safety in the weight-loss drug market.

Madison Muller, a Bloomberg News Health Reporter known for her insights into the weight loss drug industry, and David George, a Senior Research Analyst at Baird, discuss Nvidia's surprising shift in trade dynamics with China. They delve into the repercussions of the U.S. government's decision to allow AI chip exports, potentially generating billions for tech firms. The conversation also highlights the evolving U.S.-China tech rivalry and its impact on global market trends, touching on tariffs and the implications for companies navigating these turbulent waters.

Nancy Cook, a national political reporter who covers GOP dynamics; Jennifer Welch, a geoeconomics analyst focused on energy and markets; and Madison Muller, a pharma and biotech reporter. They dig into Trump’s Iran stance fracturing his movement. They discuss oil-price spikes, inflation risks and regional fallout. They also cover pharmaceutical deals, FDA moves and market reactions.

Jennifer Rhee, senior litigation analyst who explains the DOJ settlement with Live Nation and its likely amphitheater divestitures. Madison Muller, health reporter covering pharma industry moves, on Novo Nordisk’s renewed deal with Hims & Hers for weight‑loss drugs. Deborah Aitken, luxury goods analyst, on how Middle East conflict could dent luxury growth. Bess Freedman, NYC real estate CEO, on geopolitical risk, cash buyers, and housing supply constraints.

Anurag Rana, a senior technology analyst, discusses Oracle's significant stock drop linked to rising AI spending and the investor jitters around revenue conversion. Lindsey Dutch, a consumer hardlines expert, shares insights on the expanding retail landscape, anticipating strong revenue growth through 2026. Madison Muller, covering health news, highlights Eli Lilly's groundbreaking obesity drug trials showing remarkable weight loss results, stirring excitement in the pharmaceutical market.

Madison Muller, a Bloomberg News health reporter, delves into activist investor Starboard Value's $1 billion stake in Pfizer, revealing the company's struggles post-COVID. Katie Thomas analyzes consumer spending trends, especially for Halloween. Dr. Ellen Wald discusses the impact of Middle Eastern tensions on oil prices, while Teri Williams highlights the economic progress of Black women in promoting inclusivity. Jamie Battmer offers insights on today's investment landscape amidst these challenges.